Neogenomics Inc (NEO)

R&D to Revenue

5.34%

Quarterly · Period ending:

NEO logo

NEO R&D to Revenue

Latest reported5.34%
NEO Quarterly R&D/Revenue (0.00% → 5.34%)
High-resolution chart · PNG

NEO r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Neogenomics Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.